Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1
5-Year Impact Factor – 2.2
Scopus CiteScore – 3.4 (CiteScore Tracker 3.4)
Index Copernicus  – 161.11; MEiN – 140 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2015, vol. 24, nr 4, July-August, p. 623–627

doi: 10.17219/acem/47735

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Relationship Between Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio and Obstructive Sleep Apnea Syndrome

Sabri Koseoglu1,A,B,C,D,E,F, Kursat M. Ozcan1,A,B,C,D,E,F, Aykut Ikinciogullari1,A,B,C,D,E,F, Mehmet A. Cetin1,A,B,C,D,E,F, Erol Yildirim2,A,B,C,D,E,F, Huseyin Dere1,A,B,C,D,E,F

1 Ankara Numune Education and Research Hospital, ENT Clinic, Turkey

2 Kars State Hospital, ENT Clinic, Turkey


Background. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) give information about many diseases. An increase in inflammation markers occurs in patients with obstructive sleep apnea syndrome (OSAS).
Objectives. The aim of this study is to determine the relationship between OSAS and NLR and PLR values.
Material and Methods. Two hundred eighty four patients with complaints of snoring and excessive daytime sleepiness were included in the study. Polysomnography had been performed on all patients and the control group. Fourty eight of these patients with apnea-hypopnea index (AHI) less than 5 (pure snoring) were included in the control group, 67 patients with AHI between 5 and 14.9 in the mild OSAS group, 61 patients with AHI between 15 and 29.9 in the moderate OSAS group and 108 patients with AHI more than 30 in the severe OSAS group. NLR and PLR values were calculated from the complete blood count (CBC) analysis of the patients and control group. The OSAS and control groups were compared by age, gender, body mass index (BMI) and PSG parameters as well as NLR and PLR values.
Results. The PLR value in the OSAS group was found to be less than in the control group (p = 0.006). As the non-REM AHI increased, the value of PLR decreased. As the nocturnal time spent with arterial oxygen saturation < 90% increased, the value of NLR was determined to increase.
Conclusion. NLR and PLR values can give valuable information in OSAS.

Key words

obstructive sleep apnea, neutrophil, lymphocyte, inflammation.

References (28)

  1. Mirrakhimov AE, Sooronbaev T, Mirrakhimov EM: Prevalence of obstructive sleep apnea in Asian adults: a systematic review of the literature. BMC Pulm Med 2013, 13, 10.
  2. Lurie A: Obstructive sleep apnea in adults: epidemiology, clinical presentation, and treatment options. Adv Cardiol 2011, 46, 1–42.
  3. Olson EJ, Park JG, Morgenthaler TI: Obstructive sleep apnea-hypopnea syndrome. Prim Care 2005, 32, 329–359.
  4. Edinger JD, Carwile S, Miller P: Psychological status, syndromatic measures, and compliance with nasal CPAP therapy for sleep apnea. Percept Mot Skills 1994, 78, 1116–1118.
  5. Fusetti M, Fioretti AB, Valenti M: Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome. Acta Otorhinolaryngol Ital 2012, 32, 320–325.
  6. Marin JM, Carrizo SJ, Vicente E, Agusti AG: Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365, 1046–1053.
  7. Marshall NS, Wong KK, Liu PY: Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 2008, 31, 1079–1085.
  8. Martinez-Garcia MA, Soler-Cataluna JJ, Ejarque-Martinez L: Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study. Am J Respir Crit Care Med 2009, 180, 36–41.
  9. Santos T, Drummond M, Botelho F: Erectile dysfunction in obstructive sleep apnea syndrome – prevalence and determinants. Rev Port Pneumol 2012, 18, 64–71.
  10. Takaesu Y, Inoue Y, Komada Y: Effects of nasal continuous positive airway pressure on panic disorder comorbid with obstructive sleep apnea syndrome. Sleep Med 2012, 13, 156–160.
  11. McNicholas WT: Diagnosis of obstructive sleep apnea in adults. Proc Am Thorac Soc 2008, 5, 154–160.
  12. Wang D, Yang JX, Cao DY: Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma. Onco Targets Ther 2013, 6, 211–216.
  13. Bhat T, Teli S, Rijal J: Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther 2013, 11, 55–59.
  14. Proctor MJ, McMillan DC, Morrison DS: A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br J Cancer 2012, 107, 695–699.
  15. Svensson M, Venge P, Janson C, Lindberg E: Relationship between sleep-disordered breathing and markers of systemic inflammation in women from the general population. J Sleep Res. 2012, 21, 147–154.
  16. McNicholas WT, Bonsigore MR: Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007, 29, 156–178.
  17. Yardim-Akaydin S, Caliskan-Can E, Firat H: Influence of Gender on C-Reactive Protein, Fibrinogen, and Erythrocyte Sedimentation Rate in Obstructive Sleep Apnea. Antiinflamm Antiallergy Agents Med Chem 2013.
  18. Baessler A, Nadeem R, Harvey M: Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers – a meta-analysis. J Inflamm (Lond) 2013, 10, 13.
  19. Akpinar ME, Yigit O, Altundag A: Salivary and serum myeloperoxidase in obstructive sleep apnea. J Otolaryngol Head Neck Surg 2012, 41, 215–221.
  20. Gary T, Pichler M, Belaj K: Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLoS One 2013, 8, e67688.
  21. Azab B, Shah N, Akerman M, McGinn JT Jr: Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis 2012, 34, 326–334.
  22. Raungkaewmanee S, Tangjitgamol S, Manusirivithaya S: Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer. J Gynecol Oncol 2012, 23, 265–273.
  23. Nena E, Papanas N, Steiropoulos P: Mean Platelet Volume and Platelet Distribution Width in non-diabetic subjects with obstructive sleep apnoea syndrome: new indices of severity? Platelets 2012, 23, 447–454.
  24. Varol E, Ozturk O, Gonca T: Mean platelet volume is increased in patients with severe obstructive sleep apnea. Scand J Clin Lab Invest 2010, 70, 497–502.
  25. Giles H, Smith RE, Martin JF: Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest 1994, 24, 69–72.
  26. Ulu S, Ulu MS, Bucak A: Neutrophil-to-Lymphocyte Ratio as a New, Quick, and Reliable Indicator for Predicting Diagnosis and Prognosis of Idiopathic Sudden Sensorineural Hearing Loss. Otol Neurotol 2013, 34, 1400–1404.
  27. Rudiger A, Burckhardt OA, Harpes P: The relative lymphocyte count on hospital admission is a risk factor for long-term mortality in patients with acute heart failure. Am J Emerg Med 2006, 24, 451–454.
  28. Tamhane UU, Aneja S, Montgomery D: Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 2008, 102, 653–657.